Metonitazene
| Metonitazene | |
|---|---|
| Salts [] | |
|---|---|
| Metonitazene hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 382.5 g/mol [1] |
| Predicted LogP | 3.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H26N4O3 [1] |
| IUPAC name | N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamine [1] |
| SMILES | CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OC [1] |
| InChI | InChI=1S/C21H26N4O3/c1-4-23(5-2)12-13-24-20-11-8-17(25(26)27)15-19(20)22-21(24)14-16-6-9-18(28-3)10-7-16/h6-11,15H,4-5,12-14H2,1-3H3 [1] |
| InChIKey | HNGZTLMRQTVPBH-UHFFFAOYSA-N [1] |
Metonitazene (also known as Dea no. 9757, N,N-diethyl-2-(2-((4-methoxyphenyl)methyl)-5-nitrobenzimidazol-1-yl)ethanamine, N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, Dtxcid501766642, Chebi:234362, Benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-methoxybenzyl)-5-nitro-, N,N-Diethyl-2-((4-methoxyphenyl)methyl)-5-nitro-1H-benzimidazole-1-ethanamine, N,N-diethyl-2-[(4-methoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine, 1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-((4-methoxyphenyl)methyl)-5-nitro- or 1-(Diethylamino)ethyl-2-(4-methoxybenzyl)-5-nitrobenzimidazole) is a opioid substance of the nitazene class.
Chemistry
Salts []
Stereochemistry []
Metonitazene is a achiral mixture.
Reagents
There are currently 10 reagent-interactions on DrugsPRO
| Reagent | Color change |
|---|---|
| Marquis | |
| Mecke | |
| Mandelin | |
| Liebermann | |
| Froehde | |
| Robadope | |
| Simon's | |
| Morris | |
| Zimmermann | |
| Cannabis (4-AP) |
Subjective effects []
Experience reports
Erowid
There are currently 2 experience reports involving metonitazene on Erowid: []
Legal status []
- Brazil: Metonitazene is a F1 substance.
- Germany: Metonitazene is a Anlage II substance.
- United Kingdom: Metonitazene is a Class A substance.
- United States: Metonitazene is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
- Opioid
- Substituted nitazenes (zenes)
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 53316366, Metonitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/53316366
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metonitazene. UNII: A7FF4K4CWB. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/A7FF4K4CWB